BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 768906)

  • 21. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of arterial hypertension with acebutolol. Clinical results].
    Fourcade J; Mimran A; Barjon P
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3289-93. PubMed ID: 768912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vasodilator treatment of left ventricular insufficiency in the acute stage of myocardial infarction].
    Fauvel JM; Donzeau JP; Bounhoure JP; Bernadet P; Calazel P
    Arch Mal Coeur Vaiss; 1977 Aug; 70(8):825-32. PubMed ID: 409363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous trinitroglycerin during acute myocardial infarction with cardiac failure. Cooperative study of 68 patients (author's transl)].
    Le Pailleur C
    Nouv Presse Med; 1979 Jan; 8(4):257-60. PubMed ID: 122016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)].
    Plouin PF; Comoy E; Bohuon C; Corvol P; Ménard J
    Nouv Presse Med; 1979 May; 8(23):1905-9. PubMed ID: 461152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of beta blockade with acebutolol on hypertension, hemodynamics, and fluid volume.
    Dreslinski GR; Aristimuno GG; Messerli FH; Suarez DH; Frohlich ED
    Clin Pharmacol Ther; 1979 Nov; 26(5):562-5. PubMed ID: 498697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol.
    Frick MH; Valle M; Korhola O; Hekali P; Riihimäki E
    Ann Clin Res; 1978 Apr; 10(2):66-70. PubMed ID: 28072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities.
    Shin BS; Do YS; Cho HS; Kim DI; Hahm TS; Kim CS; Ko JS; Bang SR; Park KB; Cho SK; Park HS; Kim S
    J Vasc Interv Radiol; 2010 Jan; 21(1):81-9. PubMed ID: 20123194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response effects of cardioselective beta blockade in coronary artery disease.
    Silke B; Nelson G; Hussain M; Verma SP; Taylor SH
    Clin Pharmacol Ther; 1984 Jul; 36(1):40-6. PubMed ID: 6734047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and coronary hemodynamic effects of beta-adrenoceptor blocking agents in coronary artery disease.
    Yabe Y; Morishita T
    Jpn Heart J; 1987 Sep; 28(5):675-86. PubMed ID: 3430729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic parameters and plasma-renin activity following intravenous dihydralazine administration--a contribution to the regulation of renin].
    Börner H; Teichmann G
    Z Gesamte Inn Med; 1978 Jan; 33(2):44-8. PubMed ID: 636499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
    Matsuura H; Masaoka S; Kanazawa I; Murano S; Tsuchioka Y; Kajiyama G
    Jpn J Med; 1989; 28(1):8-15. PubMed ID: 2657144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central inhibition of sympathetic overdrive by clonidine in acute myocardial infarction with systolic hypertension. Haemodynamic study.
    Renard M; Liebens I; Waterschoot P; Bernard R
    Angiology; 1986 Sep; 37(9):633-41. PubMed ID: 3767070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).
    Menard J; Bertagna X; N'Guyen PT; Degoulet P; Corvol P
    Am J Med; 1976 May; 60(6):886-90. PubMed ID: 14503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP; Roberts AJ; Laragh JH
    Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic profile of acebutolol in acute myocardial infarction.
    Wan SH; Seah CS; Teh LB; Letchmana K
    Ann Acad Med Singap; 1980 Oct; 9(4):440-5. PubMed ID: 6113810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of acebutolol on cardiovascular function in man.
    Dalal JJ; Ross PJ; Wong K; Sheridan DJ; Ruttley MS; Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1981 Mar; 11(3):265-8. PubMed ID: 7213527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.
    Trimarco B; Ricciardelli B; De Luca N; Volpe M; Veniero A; Cuocolo A; Condorelli M
    Am J Cardiol; 1984 Mar; 53(6):791-6. PubMed ID: 6230921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioselective beta-blockade with atenolol and acebutolol following acute myocardial infarction: a multiple-dose haemodynamic comparison.
    Frais MA; Silke B; Ahuja RC; Verma SP; Nelson GI; Taylor SH
    J Cardiovasc Pharmacol; 1985; 7(1):80-5. PubMed ID: 2580155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lowering of daytime blood pressures with a single daily dose of acebutolol in ambulant hypertensives.
    Mehta SK; Goldberg AD; Walsh JT
    Clin Cardiol; 1985 Jan; 8(1):34-9. PubMed ID: 3967403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.